Johnson & Johnson Innovation - JJDC as of June 30, 2021
Portfolio Holdings for Johnson & Johnson Innovation - JJDC
Johnson & Johnson Innovation - JJDC holds 21 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 30.0 | $293M | 3.4M | 86.79 | |
| Arrowhead Pharmaceuticals (ARWR) | 27.6 | $270M | 3.3M | 82.82 | |
| Protagonist Therapeutics (PTGX) | 11.2 | $110M | 2.4M | 44.88 | |
| CVRX (CVRX) | 10.0 | $98M | 3.5M | 28.00 | |
| Legend Biotech Corporation Sponsored Ads (LEGN) | 6.8 | $67M | 1.6M | 41.05 | |
| Meiragtx Holdings (MGTX) | 4.6 | $45M | 2.9M | 15.50 | |
| Fusion Pharmaceuticals | 3.0 | $30M | 3.7M | 8.08 | |
| Vor Biopharma (VOR) | 2.0 | $20M | 1.1M | 18.65 | |
| Chardan Healthcare Acqu- Ord | 1.2 | $12M | 2.1M | 5.46 | |
| Therapeutics Acquisition Cor Com Cl A | 1.1 | $10M | 1.0M | 10.27 | |
| Adicet Bio (ACET) | 0.8 | $7.5M | 729k | 10.29 | |
| Phasebio Pharmaceuticals | 0.6 | $6.0M | 1.6M | 3.72 | |
| Aldeyra Therapeutics (ALDX) | 0.5 | $4.5M | 395k | 11.33 | |
| Castlight Health CL B | 0.2 | $2.1M | 811k | 2.63 | |
| Neuropace (NPCE) | 0.1 | $1.3M | 55k | 23.79 | |
| Zymergen | 0.1 | $662k | 17k | 39.99 | |
| Tracon Pharmaceuticals | 0.1 | $545k | 84k | 6.49 | |
| Catalyst Biosciences | 0.0 | $290k | 67k | 4.33 | |
| Graybug Vision Com Shs | 0.0 | $269k | 50k | 5.43 | |
| Pulmonx Corp (LUNG) | 0.0 | $249k | 5.6k | 44.16 | |
| Senseonics Hldgs (SENS) | 0.0 | $210k | 55k | 3.84 |
